To explore the prognostic factors of MDS patients with SF3B1 mutation, we regarded MDS patients with SF3B1 mutation in Zhejiang Province as the experimental cohort (n=106) and MDS patients with SF3B1 mutation from GSE58831 database (23) as the validation cohort (n=32). The gene discussed is SF3B1; the disease is myelodysplastic syndrome.